Sanofi (NASDAQ:SNY – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $50.11, but opened at $48.22. Sanofi shares last traded at $48.61, with a volume of 1,008,582 shares traded.
Sanofi Stock Performance
The company has a market capitalization of $121.77 billion, a P/E ratio of 24.16, a PEG ratio of 1.50 and a beta of 0.60. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The company’s 50-day moving average is $48.59 and its two-hundred day moving average is $48.54.
Sanofi (NASDAQ:SNY – Get Free Report) last released its earnings results on Thursday, April 25th. The company reported $0.96 EPS for the quarter, meeting analysts’ consensus estimates of $0.96. The business had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. Equities analysts anticipate that Sanofi will post 4.13 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
About Sanofi
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
See Also
- Five stocks we like better than Sanofi
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- The How and Why of Investing in Gold Stocks
- Progress Software Stock Back in the Green After Beating Forecasts
- What is a Low P/E Ratio and What Does it Tell Investors?
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.